Invest in

Biotech Breakthroughs

19.5%
9.9%
0.4%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
19.5%
9.9%
0.4%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
34.0% Cancer 5.8%
20.9% Amgen Inc. AMGN 2.3%
11.2% Celgene Corporation CELG 22.3%
1.0% Medivation Inc. MDVN 14.1%
0.9% Spectrum Pharmaceuticals Inc. SPPI 11.0%
17.8% Infectious Diseases 24.8%
15.4% Gilead Sciences Inc. GILD 24.3%
1.5% Opko Health Inc. OPK 41.0%
0.9% Emergent Biosolutions Inc. EBS 5.3%
17.4% Other Diseases 32.5%
6.3% Regeneron Pharmaceuticals Inc. REGN 30.0%
4.4% Alexion Pharmaceuticals Inc. ALXN 38.3%
3.6% Vertex Pharmaceuticals Incorporated VRTX 28.9%
2.0% United Therapeutics Corporation UTHR 35.6%
1.1% Repligen Corporation RGEN 29.1%
17.0% Autoimmune Disorders 28.3%
10.4% Biogen Inc. BIIB 27.9%
2.9% Incyte Corporation INCY 23.3%
2.7% BioMarin Pharmaceutical Inc. BMRN 35.2%
1.0% ACADIA Pharmaceuticals Inc. ACAD 27.5%
13.8% Research & Diagnostics 14.4%
5.2% Quintiles Transnational Holdings Inc. Q 4.4%
3.8% Illumina Inc. ILMN 30.4%
3.8% Qiagen N.V. QGEN 18.0%
1.0% Meridian Bioscience Inc. VIVO 8.2%

Quotes delayed 15 mins. Currently Jul 23, 2016 3:13:20 PM. Fields are marked with -- when data is unavailable.